AU2067501A - Human oxidoreductase proteins - Google Patents

Human oxidoreductase proteins

Info

Publication number
AU2067501A
AU2067501A AU20675/01A AU2067501A AU2067501A AU 2067501 A AU2067501 A AU 2067501A AU 20675/01 A AU20675/01 A AU 20675/01A AU 2067501 A AU2067501 A AU 2067501A AU 2067501 A AU2067501 A AU 2067501A
Authority
AU
Australia
Prior art keywords
oxidoreductase proteins
human oxidoreductase
human
proteins
oxidoreductase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20675/01A
Inventor
Yalda Azimzai
Mariah R. Baughn
Jennifer L. Hillman
Preeti Lal
Dyung Aina M. Lu
Y. Tom Tang
Henry Yue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Publication of AU2067501A publication Critical patent/AU2067501A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
AU20675/01A 1999-12-16 2000-12-07 Human oxidoreductase proteins Abandoned AU2067501A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17236799P 1999-12-16 1999-12-16
US60172367 1999-12-16
PCT/US2000/033158 WO2001044448A2 (en) 1999-12-16 2000-12-07 Human oxidoreductase proteins

Publications (1)

Publication Number Publication Date
AU2067501A true AU2067501A (en) 2001-06-25

Family

ID=22627426

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20675/01A Abandoned AU2067501A (en) 1999-12-16 2000-12-07 Human oxidoreductase proteins

Country Status (5)

Country Link
EP (1) EP1242583A2 (en)
JP (1) JP2003516750A (en)
AU (1) AU2067501A (en)
CA (1) CA2394160A1 (en)
WO (1) WO2001044448A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020081679A1 (en) * 1999-10-22 2002-06-27 Millennium Pharmaceuticals, Inc. NARC8 programmed cell-death-associated molecules and uses thereof
US7166428B2 (en) 2000-08-31 2007-01-23 Millennium Pharmaceuticals, Inc. 62112, a novel human dehydrogenase and uses thereof
US6613554B2 (en) * 2001-03-26 2003-09-02 Applera Corporation Isolated human enzyme, nucleic acid molecules encoding human enzyme, and uses thereof
AU2002309513A1 (en) * 2001-03-27 2002-10-08 Human Genome Sciences, Inc. Human secreted proteins
EP1480670A2 (en) * 2002-03-07 2004-12-01 DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung Cg3842 homologous proteins involved in the regulation of energy homeostasis
EP1700921A3 (en) * 2002-05-27 2006-09-20 Bayer HealthCare AG Regulation of a human asparagine-hydroxylase
AU2003286581A1 (en) * 2002-10-22 2004-05-13 Incyte Corporation Secreted proteins
WO2004069194A2 (en) * 2003-02-03 2004-08-19 The Brigham And Women's Hospital, Inc. Use of the oxidoreductase ncb50r for diagnosings and treating diabetes
WO2004103316A2 (en) * 2003-05-21 2004-12-02 Xenon Genetics Inc. Orp9, a novel therapeutic target for increasing hdl levels
EP1644494A2 (en) * 2003-06-17 2006-04-12 Devgen NV Alcohol dehydrogenase sequences useful for developing compounds for the prevention and/or treatment of metabolic diseases
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics

Also Published As

Publication number Publication date
EP1242583A2 (en) 2002-09-25
WO2001044448A3 (en) 2002-01-17
WO2001044448A2 (en) 2001-06-21
CA2394160A1 (en) 2001-06-21
JP2003516750A (en) 2003-05-20

Similar Documents

Publication Publication Date Title
AU6030398A (en) Human proteins
AU6364700A (en) Human synthetases
AU6045900A (en) Interaction-activated proteins
AU1608201A (en) Human zven proteins
AU7748200A (en) Hypoxia-related human genes, proteins, and uses thereof
AU5744200A (en) Human transport proteins
AU3393900A (en) Human secretory proteins
AU2067501A (en) Human oxidoreductase proteins
AU2001286721A1 (en) Human interleukin-four induced protein
AU3916400A (en) Human transmembrane proteins
AU4338100A (en) Secreted human proteins
AU3609300A (en) Human serpin proteins
AU7089800A (en) 29 human cancer associated proteins
AU7508100A (en) Human seizure related proteins
AU4188500A (en) Protein c derivatives
AU9017598A (en) Human frezzled-like protein
AU4483500A (en) Human membrane-associated proteins
AU1751801A (en) Protein c derivatives
AU2271801A (en) Human slit polypeptide zslit3
AU2136401A (en) P450rai-2 and related proteins
AU1881200A (en) Novel proteins
AU4456800A (en) Human hac3
AU5034200A (en) Oxidoreductase proteins
AU4843799A (en) Human oxidoreductase proteins
AU2593199A (en) Human smn-like protein

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase